Dr. Althea
Dr. Althea Brings 345 Relief Serum to the US K-Beauty Shelf
Dr. Althea 345 Relief Serum is a fragrance-free calming serum positioned for acne-prone and sensitive skin, priced at $22.
NewBeauty listed Dr. Althea 345 Relief Serum in its May 2026 launch list at $22, and the brand positions it as a fragrance-free calming serum for sensitive skin using its 3-4-5 care concept.
Dr. Althea
345 Relief Serum
$22
Dr. Althea is moving a cream-led K-beauty franchise into serum format at an accessible $22 price point. The launch matters for shoppers who want barrier support without fragrance, especially when active-heavy routines are causing dryness or visible redness.
Brand claims
- ✓Fragrance-free calming serum for sensitive skin
- ✓Built around the brand's 3-4-5 Triple Reset Care positioning
- ✓Marketed as acne-friendly and barrier-supportive
- ✓Featured in NewBeauty's May 2026 launch list
Why this matters
Dr. Althea is already familiar to US K-beauty shoppers through its 345 Relief Cream, so the new 345 Relief Serum gives that calming franchise a lighter, layerable step. NewBeauty included the serum in its May 2026 launch list at $22, which keeps it in the accessible range for shoppers building a barrier-repair routine.
What is new
The serum is described as acne-friendly and fragrance-free, with the brand’s Triple Reset Care concept positioned around soothing, nourishing and restoring skin in one step. That makes it a fit for routines where retinoids, exfoliating acids or benzoyl peroxide are doing the heavy work but leaving skin reactive.
Who should watch it
This is most relevant for sensitive, combination or breakout-prone skin that still needs hydration. It is not a substitute for prescription acne care, and shoppers who react to botanical extracts should still read the full INCI list before layering it under SPF or makeup.
Availability
Dr. Althea lists the serum on its official global storefront, and NewBeauty’s launch coverage links to a US Amazon listing. We may earn a commission on qualifying links, but no rating or clinical result is being claimed here.
What we are watching next
The useful follow-up signal will be whether US shoppers with reactive skin report pilling under sunscreen or makeup, since calming serums often fail on texture rather than ingredient story. We will also watch whether Amazon availability stays stable beyond launch week.